期刊文献+

RNA沉默PI3K、AKT基因对人卵巢癌SKOV3细胞增殖和凋亡的比较 被引量:2

Comparison of RNA interference targeting PI3K and AKT on proliferation and apoptosis of ovarian cancer SKOV3 cells
下载PDF
导出
摘要 目的探讨RNA技术分别沉默PI3K、AKT基因表达对人卵巢癌SKOV3细胞增殖与凋亡的比较,从而为卵巢癌的基因治疗提供有效的理论依据。方法体外合成PI3Kp110α、AKT序列特异性双链RNA(dsRNA),用lipofectamin2000转染人卵巢癌SKOV3细胞,采用MTT法检测细胞活性,流式细胞仪法检测细胞凋亡率。结果 MTT法检测siRNA-AKT组细胞增殖能力降低大于siRNA-PI3K组,差异有统计学意义(P<0.05),而流式细胞术检测siRNA-AKT组细胞凋亡率则高于siRNA-PI3K组,差异有统计学意义(P<0.05)。结论体外合成靶向AKT的siRNA更能有效地抑制人卵巢癌SKOV3细胞增殖及诱导细胞凋亡。PI3K通路并非AKT激活的唯一途径。 Objective To investigate the comparison of RNA interference targeting PI3K p110α or AKT on proliferation and apoptosis of ovarian cancer SKOV3 cells, which will offer an effective theoretical basis of ovarian cancer. Methods SKOV3 cells were transfected with PI3K pll0a or AKT sequence-specific dsRNA by lipofectamin2000. The cell activity was detected by MTT, and the apoptosis was tested by flow cytometry. Results Cell proliferation of siRNA- AKT group reduced than in siRNA-PI3K group(P〈0.05), and apoptosis rate of siRNA-AKT group increased than in siRNA-PI3K group by flow cytometry(P〈0.05). Conclusion AKT- gene-targeted siRNA could lead to the suppression of proliferation, and induce apoptosis of SKOV3 cells. PI3K pathway is not the only way of AKT activation.
出处 《青岛医药卫生》 2013年第1期1-3,共3页 Qingdao Medical Journal
基金 山东省教育厅科技计划项目(NO:J08LH66)
关键词 RNA干扰 PI3K AKT 卵巢癌 增殖 凋亡 RNA interference PI3K AKT Ovarian cancer Proliferation Apoptosis
  • 相关文献

参考文献10

  • 1Wymann MP, Pirola L. Structure and function of phos- phoinositide 3-kinases. Biochim Biophys Acta, 1998,1436 : 127- 150.
  • 2Fruman DA, Meyers RE, Cantley LC, et al. Phosphoinositide kinases. Annu Rev Biochem,1998,67:481-507.
  • 3Vanhaesebroeck B,Waterfield MD. Signaling by distinct clas ses of phosphoinositide 3-kinases. Exp Cell Res, 1999,253 : 239- 254.
  • 4Vanhaesebroeck B,Leevers SJ,Ahmadi K, et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Bio- them, 2001,70 : 535-602.
  • 5Shayesteh L,Lu Y,Kuo WL,et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet, 1999,21 : 99-102.
  • 6Terakawa N,Kanamori Y,Yoshida S. Loss of PTEN expres- sion followed by AKT phosphorylation is a poor prognostic factor for patients with endometifial cancer[J]. Endocr Relat Cancer, 2003,10(2) :203-208.
  • 7Wang J,Wan W,Sun R,et al. Reduction of AKT2 expression inhibits chemotaxis signal transduction in human breast cancer cell[J] Cell signal, 2008,20 (6) = 1025-1034.
  • 8Tomari Y, Zamore PD. Perspective: machines for RNAi[J]. Genes Dev,2005,19(5) :517-529.
  • 9Paul CP,Good PD,Winer I, et al. Effective expression of small interfering RNA in human cells[J]. Nat Bioteehnol, 2002,20 (5) :505-508.
  • 10Wilda M, Fuchs U, Wossmann W, et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi) [J]. Oncogene,2002,21(37) :5716-5724.

同被引文献29

  • 1赵杨,郭科军,张颐,温放.细胞外信号调节激酶在卵巢癌中的表达及临床意义[J].中国肿瘤临床,2006,33(17):978-981. 被引量:5
  • 2Baker V. Treatment options for ovarian cancer[ J]. Clin Obste Gy- necol, 2001, (44) :522-530.
  • 3Feldman JD, Vician L, Crispino M, et al. KID-1, protein kinase induced by depolarization in brain [ J ]. J Biol Chem, 1998,273 (26) :16535-16543.
  • 4Deneen B, Welford SM, Ho T, et al. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncopro- reins[ J]. Mol Cell Biol,2003, 23( 11 ) :3897-3908.
  • 5Fujii C, Nakamoto Y, Lu P, et al. Aberrant expression of serine/ threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines [ J ]. Int J Cancer,2005,114 ( 2 ) :209-218.
  • 6Popivanova BK, Li YY, Zheng H, et al. Proto-oncogene, Pim-3with serine/threonine kinase activity, is aberrantly expressed in hu- man colon cancer cells and can prevent Bad-mediated apoptosis [ J ]. Cancer Sci,2007,98 ( 3 ) : 321-328.
  • 7Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [ J]. CA Cancer J Clin,2009,59(4) :225-249.
  • 8Aho TL, Sandholm J, Pehola KJ, et al. Pim-I kinase promotes in- activation of the pro-apoptotic Bad protein by phosphorylating it on the ser112 gatekeeper site[ J]. FEBS Lett,2004,57 ( 1-3 ) :43-49.
  • 9Konietzko U, Kauselmann G, Scafidi J, et al. Pim kinase expres- sion is induced by LTP stimulation and required for the consolida- tion of enduring LTP[ J]. EMBO J, 1999,18 (12) :3359-3369.
  • 10Macdonald A, Campbell DG, Toth R, et al. Pim kinases phospho- rylate multiple sites on Bad and promote 14-3-3 binding and disso- ciation from Bcl-XL [ J ]. BMC Cell Biol, 2006,7 ( 1 ) : 11862- 11991.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部